3D bioprinted cancer model to test anticancer drugs | National Institute of Biomedical Imaging and Bioengineering

3D bioprinted cancer model to test anticancer drugs | National Institute of Biomedical Imaging and Bioengineering

News Story

Science Highlight: 3D bioprinted cancer model to test anticancer drugs

A major pitfall in translating drugs from the lab bench to a viable treatment is delineating the differences that occur inside a 2D petri dish versus the human body, which is inherently 3D. Often, what is observed in a plastic petri dish fails to accurately replicate the conditions and outcomes surrounding tumor growth in a person.

To overcome this challenge, NIBIB-funded researchers at the University of Minnesota (UMN) created a new, dynamic 3D bioprinted tumor model in a laboratory dish to screen anticancer drugs and study the spread of cancer and primary site tumor growth.

Read more…